CYPHERPUNK TECHNOLOGIES INC. Shares Outstanding (Cover Page)
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Shares Outstanding (Cover Page) of 107.76 million shares as of 2026-08-10, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-10: Entity Common Stock, Shares Outstanding 107.76M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 106.46M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 89.98M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 56.65M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 107.76M shares 10-Q · filed 2026-08-12 |
| 2026-05-12 | 106.46M shares 10-Q · filed 2026-05-14 |
| 2026-03-11 | 89.98M shares 10-K · filed 2026-03-16 |
| 2025-11-10 | 56.65M shares 10-Q · filed 2025-11-12 |
| 2025-08-11 | 41.44M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 41.44M shares 10-Q · filed 2025-05-13 |
| 2025-03-20 | 41.26M shares 10-K · filed 2025-03-26 |
| 2024-11-08 | 38.32M shares 10-Q · filed 2024-11-13 |
| 2024-08-08 | 38.26M shares 10-Q · filed 2024-08-12 |
| 2024-05-09 | 38.26M shares 10-Q · filed 2024-05-13 |
| 2024-03-13 | 25.60M shares 10-K · filed 2024-03-18 |
| 2023-11-09 | 25.57M shares 10-Q · filed 2023-11-13 |
| 2023-08-09 | 25.57M shares 10-Q · filed 2023-08-14 |
| 2023-05-10 | 119.41M shares 10-Q · filed 2023-05-15 |
| 2023-03-20 | 118.75M shares 10-K · filed 2023-03-24 |
| 2022-11-09 | 99.02M shares 10-Q · filed 2022-11-14 |
| 2022-08-10 | 99.02M shares 10-Q · filed 2022-08-12 |
| 2022-05-10 | 88.32M shares 10-Q · filed 2022-05-13 |
| 2022-03-08 | 88.32M shares 10-K · filed 2022-03-11 |
| 2021-11-10 | 88.32M shares 10-Q · filed 2021-11-12 |
| 2021-08-10 | 59.67M shares 10-Q · filed 2021-08-13 |
| 2021-05-10 | 59.67M shares 10-Q · filed 2021-05-14 |
| 2021-03-09 | 59.66M shares 10-K · filed 2021-03-12 |
| 2020-11-10 | 59.66M shares 10-Q · filed 2020-11-12 |
| 2020-08-10 | 59.66M shares 10-Q · filed 2020-08-13 |
| 2020-05-12 | 35.80M shares 10-Q · filed 2020-05-14 |
| 2020-03-11 | 35.80M shares 10-K · filed 2020-03-16 |
| 2019-11-12 | 24.19M shares 10-Q · filed 2019-11-14 |
| 2019-08-06 | 24.04M shares 10-Q · filed 2019-08-09 |
| 2019-05-10 | 22.95M shares 10-Q · filed 2019-05-15 |
| 2019-03-26 | 22.26M shares 10-K · filed 2019-04-01 |
| 2018-11-06 | 14.70M shares 10-Q · filed 2018-11-09 |
| 2018-08-06 | 14.70M shares 10-Q · filed 2018-08-08 |
| 2018-05-08 | 14.70M shares 10-Q/A · filed 2018-08-08 |
| 2018-02-21 | 12.35M shares 10-K · filed 2018-02-23 |
| 2017-11-08 | 9.40M shares 10-Q · filed 2017-11-13 |
| 2017-08-09 | 9.40M shares 10-Q · filed 2017-08-11 |
| 2017-05-10 | 9.39M shares 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |